Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

PFSA stock hub

Profusa, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

PFSAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
PFSA
In the news

Latest news · PFSA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROEn/a
P25 -105.6P50 -46.5P75 -3.1
ROICn/a
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All PFSA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
159
Groups with data
11
Currency
USD
Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

21
MetricValue
Cik
0001859807
Company name
Profusa, Inc.
Country
United States
Country code
US
Cusip
74319X207
Employees
15
Enterprise value
$15.3M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
Isin
US74319X2071
Last refreshed
2026-05-10
Market cap
$2.3M
Market cap category
Nano-Cap
Price
$0.52
Price currency
USD
Sector
Healthcare
Sic
3841
Symbol
PFSA
Website
https://profusa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

2
MetricValue
Earnings Yield
-1,574.76%
FCF yield
-714.61%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

6
MetricValue
Net Income
$-35.8M
Net Income Growth Years
0%
Profit Per Employee
$-2.4M
ROA
-505.7
Roa5y
-205.9
ROCE
149.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
-99.94%
Cagr3y
-91.29%
EPS Growth Quarters
2
EPS Growth Years
1
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
$3.8M
Cash
$1.8M
Current Assets
$3.8M
Current Liabilities
$22.3M
Debt
$14.8M
Equity
$-26.7M
Interest Coverage
-5.44
Liabilities
$30.4M
Long Term Assets
$11,000
Long Term Liabilities
$8.2M
Net Cash
$-13M
Net Cash By Market Cap
$-573
Tangible Book Value
$-26.7M
Tangible Book Value Per Share
$-21.64
WACC
24.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
0.17
Net Working Capital
$-13.3M
Quick ratio
0.08
Working Capital
$-18.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-1,195.32%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
1Y total return
-99.94%
200-day SMA
14.85
3Y total return
-99.93%
50-day SMA
0.74
50-day SMA vs 200-day SMA
50under200
All Time High
975
All Time High Change
-99.95%
All Time High Date
2024-05-21
All Time Low
0.41
All Time Low Change
25.77%
All Time Low Date
2026-03-19
ATR
0.13
Beta
0.45
Beta1y
3.45
Beta2y
1.04
Ch YTD
-93.44
High
0.52
High52
957
High52 Date
2025-05-20
High52ch
-99.95%
Low
0.47
Low52
0.41
Low52 Date
2026-03-19
Low52ch
25.77%
Ma50ch
-30.28%
Premarket Change Percent
2.45
Premarket Price
$0.5
Premarket Volume
60,985
Price vs 200-day SMA
-96.53%
RSI
39.22
RSI Monthly
9.59
RSI Weekly
12.21
Sharpe ratio
-1.12x
Sortino ratio
-2.15
Total Return
-1,195.32%
Tr YTD
-93.44
Tr1m
-58.74%
Tr1w
-8.14%
Tr3m
-88.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
$-27.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
4,296,374%
Float Percent
97.42%
Net Borrowing
19,841,000
Shares Insiders
2.04%
Shares Institutions
2.23%
Shares Out
4,410,268
Shares Qo Q
103.94%
Shares Yo Y
1,195.32%
Short Float
0.88%
Short Shares
0.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
$-17.1M
Average Volume
1,588,525.95x
Bv Per Share
-21.64
CAPEX
$-8,000
Ch1m
-58.74
Ch1w
-8.14
Ch1y
-99.94
Ch3m
-88.2
Ch3y
-99.93
Ch6m
-96.22
Change
5.27%
Change From Open
3.16
Close
0.49
Days Gap
2.04
Dollar Volume
144,344.1
Earnings Date
2026-05-26
Earnings Time
bmo
EBIT
$-27.7M
EPS
$-107
F Score
2
FCF
$-16.3M
FCF EV Yield
-106.17x
FCF Per Share
$-3.69
Financing CF
19,843,000
Fiscal Year End
December
Founded
2,009
Investing CF
-2,008,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-04-15
Last Report Date
2025-12-31
Last Split Date
2026-02-09
Last Split Type
Reverse
Last10k Filing Date
2026-04-15
Ma150
7.96
Ma150ch
-93.52%
Ma20
0.59
Ma20ch
-12.87%
Net CF
1,587,000
Next Earnings Date
2026-05-26
Open
0.5
Optionable
No
Position In Range
100
Post Close
0.52
Postmarket Change Percent
-4.92
Postmarket Price
$0.49
Ppne
8,000
Pre Close
0.49
Price Date
2026-05-08
Relative Volume
0.18x
Share Based Comp
891,000
Tr6m
-96.22%
Us State
California
Volume
279,845
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does PFSA pay a dividend?

Capital-return profile for this ticker.

Performance

PFSA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-99.9%
S&P 500 1Y: n/a
3Y total return
-99.9%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns PFSA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+2.2%
Float: +97.4% of shares outstanding
Insider ownership
+2.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+0.9%
Float sold short by bearish positioning
Y/Y dilution
+1195.3%
Negative means the company is buying back shares.
Technical

PFSA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
39.2
Neutral momentum band
Price vs 200-day MA
-96.5%
50/200-day relationship not available
Beta (5Y)
0.45
Less volatile than the market
Sharpe ratio
-1.12
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About PFSA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PFSA stock rating?

Profusa, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PFSA analysis?

The full report lives at /stocks/PFSA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PFSA?

The latest report frames PFSA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PFSA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.